A number of functionally important actions of proteins are mediated by short, intrinsically disordered peptide segments 1 , but the molecular interactions that allow disordered domains to mediate their effects remain a topic of active investigation 2-5 . Many K 1 channel proteins, after initial channel opening, show a timedependent reduction in current flux, termed 'inactivation', which involves movement of mobile cytosolic peptide segments (approximately 20-30 residues) into a position that physically occludes ion permeation [6] [7] [8] . Peptide segments that produce inactivation show little amino-acid identity 6, [9] [10] [11] [12] [13] and tolerate appreciable mutational substitutions 13 without disrupting the inactivation process. Solution nuclear magnetic resonance of several isolated inactivation domains reveals substantial conformational heterogeneity with only minimal tendency to ordered structures [14] [15] [16] [17] . Channel inactivation mechanisms may therefore help us to decipher how intrinsically disordered regions mediate functional effects. Whereas many aspects of inactivation of voltage-dependent K 1 channels (Kv) can be described by a simple one-step occlusion mechanism 6, 7, 18, 19 , inactivation of the voltage-dependent largeconductance Ca 21 -gated K 1 (BK) channel mediated by peptide segments of auxiliary b-subunits involves two distinguishable kinetic steps 20,21 . Here we show that two-step inactivation mediated by an intrinsically disordered BK b-subunit peptide involves a stereospecific binding interaction that precedes blockade. In contrast, blocking mediated by a Shaker Kv inactivation peptide is consistent with direct, simple occlusion by a hydrophobic segment without substantial steric requirement. The results indicate that two distinct types of molecular interaction between disordered peptide segments and their binding sites produce qualitatively similar functions.
A number of functionally important actions of proteins are mediated by short, intrinsically disordered peptide segments 1 , but the molecular interactions that allow disordered domains to mediate their effects remain a topic of active investigation [2] [3] [4] [5] . Many K 1 channel proteins, after initial channel opening, show a timedependent reduction in current flux, termed 'inactivation', which involves movement of mobile cytosolic peptide segments (approximately 20-30 residues) into a position that physically occludes ion permeation [6] [7] [8] . Peptide segments that produce inactivation show little amino-acid identity 6, [9] [10] [11] [12] [13] and tolerate appreciable mutational substitutions 13 without disrupting the inactivation process. Solution nuclear magnetic resonance of several isolated inactivation domains reveals substantial conformational heterogeneity with only minimal tendency to ordered structures [14] [15] [16] [17] . Channel inactivation mechanisms may therefore help us to decipher how intrinsically disordered regions mediate functional effects. Whereas many aspects of inactivation of voltage-dependent K 1 channels (Kv) can be described by a simple one-step occlusion mechanism 6, 7, 18, 19 , inactivation of the voltage-dependent largeconductance Ca 21 -gated K 1 (BK) channel mediated by peptide segments of auxiliary b-subunits involves two distinguishable kinetic steps 20, 21 . Here we show that two-step inactivation mediated by an intrinsically disordered BK b-subunit peptide involves a stereospecific binding interaction that precedes blockade. In contrast, blocking mediated by a Shaker Kv inactivation peptide is consistent with direct, simple occlusion by a hydrophobic segment without substantial steric requirement. The results indicate that two distinct types of molecular interaction between disordered peptide segments and their binding sites produce qualitatively similar functions.
For BK channels, inactivation is mediated by cytosolic aminoterminal segments of auxiliary b-subunits ( Supplementary Fig. 1 ) [20] [21] [22] [23] [24] . In contrast to simple models proposed for Kv N-type inactivation (C>O>I) for BK b-subunits the mechanism of inactivation involves two steps 20, 21 (C>O>O*>I*), an initial transition to a pre-inactivated conducting state (O*) followed by transition to a non-conducting inactivated state (I*) ( Supplementary Fig. 2a ). The properties of inactivation onset and recovery differ among subunits [20] [21] [22] [23] [24] , presumably dependent on the interactions of each b-subunit N terminus and the BK a-subunit. The site(s) and physical basis for this sequence of steps in BK inactivation are not understood. Here we exploit inactivation mediated by the BK b3a subunit to tease apart the molecular steps in two-step inactivation 21 . First, both the b3a subunit ( Fig. 1a ) and a b3a peptide ( Fig. 1b ) produce a slowing of BK tail currents that arises from buffering of channels between O*>I* 21 . Net current flux during the tail current greatly exceeds that expected for a population of open BK channels simply passing back to closed states 21 (Fig. 1a, b) . Second, the unique properties of the O*>I* equilibrium can be directly visualized in recordings of single BK channels during recovery from inactivation mediated either by b3a N termini 21 or by b3a peptides ( Fig. 1c ). After repolarization, inactivated single channels open to a current level of reduced amplitude, higher variance and longer duration than a typical BK channel closing (Fig. 1c ). The lower current level is a direct reflection of the rapid voltage-dependent equilibrium between states O* and I* ( Supplementary Fig. 2 ). Because the isolated b3a peptide mimics the effects of the tethered b3a N terminus ( Fig. 1a-c) , the peptide can be exploited for examination of the structural and functional basis of the two-step mechanism. Circular dichroism spectra of both a b3a peptide composed of the naturally occurring L-amino-acids and an unnatural, mirror-image peptide composed of D-amino-acid enantiomers ( Fig. 1d ) are typical of random coil and an absence of secondary structure. Solution nuclear magnetic resonance (NMR) spectra of these two peptides are identical and show minimal chemical shift dispersion ( Fig. 1e and Supplementary Fig. 3a ). The peptides also show very few inter-residue nuclear Overhauser effects (NOEs) in two-dimensional homonuclear nuclear Overhauser effect spectroscopy (NOESY) spectra ( Supplementary Fig. 3b ), consistent with intrinsic disorder.
We propose that the two-step process involves a binding step that precedes rapid motions of a flexible part of the bound N terminus in and out of a position of pore occlusion. If binding has a unique steric requirement (stereospecific binding), a b3a peptide composed entirely of D-amino acids should fail to interact with this site. Both 21-mer L-and D-amino-acid b3a peptides produced block of BK current ( Fig. 2a, d) , with block by the D-peptide of lower affinity (Supplementary Fig. 4 ). However, the D-peptide ( Fig. 2e , f) failed to mimic the ability of the L-peptide (Fig. 2b, c) to slow the tail current decay and increase tail current flux.
Because the D-peptide acts with lower affinity, the differential effects of the two peptides might arise, not from a difference in underlying mechanism, but because the O* state lifetime involving the D-peptide may be too brief to resolve. We therefore compared the ability of L-and D-peptides to block single-channel BK openings ( Fig. 2g ). With 10 mM D-peptide, we observed frequent unblocking events, consistent with its weaker affinity. After repolarization, a channel blocked by the L-peptide shows rapid unblock to the reduced current level, before unblock to a full BK open level. In contrast, a channel blocked by the D-peptide re-opens to a full current level, with no hint of the reduced current level seen with the L-peptide. When examined at higher time resolution ( Fig. 2h ), repolarization after L-peptide block resulted in an essentially instantaneous step to the level of reduced current, consistent with the properties of the O*-I* equilibrium ( Supplementary Fig. 2d-f ). Repolarization after D-peptide block revealed a finite delay before a full BK opening ( Fig. 2h ), similar to block of Kv channels 18 . The differential effects of the peptides show that stereospecific binding of L-peptide is required to produce the tail current prolongation. Although the steric binding occurs even in the absence of intrinsic structure in the free peptide, it would not be surprising that, once bound, the peptide adopts a specific structure. We also found that inactivation produced by a b3a N terminus (b3a-R16Q/R17Q/R18Q) in which the first 20 residues are uncharged ( Supplementary Fig. 5 ) retains the slow tail currents and singlechannel openings indicative of two-step inactivation. We conclude that the binding event underlying the O* state depends on hydrophobic interactions with unique steric requirements without significant contribution from electrostatic effects.
If the D-peptide blocking events arise from relatively non-specific binding, not requiring a specific steric fit but dependent on bulk hydrophobicity, the L-peptide should occasionally act in a similar fashion, in accordance with relative occupancies of non-specific and stereospecific sites. For a set of single BK channel tail openings in the presence of 10 mM b3a L-peptide, approximately 3% of tail current re-openings occurred with a well-defined latency before opening to a full open channel level; openings to a reduced current level with no latency were approximately 30-fold more abundant ( Supplementary Fig. 6a, b) . Thus, the BK channel can be blocked in two distinct ways by the b3a L-peptide. The more common re-opening to the reduced current level (O*-I*) is only observed with the L-peptide. However, re-opening to a fully open level is observed more rarely with L-peptide, and this behaviour is similar to the one-step block (O-I) characteristic of the b3a D-peptide or block of the Shaker channel 18 . Because recovery from I* is much more rapid ( Supplementary Fig. 2 ) than for the rarer form of block (O-I), the peptide position within the channel must differ markedly in each case.
We next asked whether peptide blockade of Shaker Kv channels may show a similar steric dependence. Shaker inactivation peptides, which also show little defined structure 14 , tolerate appreciable amino-acid substitution without altering inactivation as long as bulk hydrophobicity is maintained 13 . If block largely reflects bulk hydrophobicity with no steric requirement, L-and D-Shaker peptides should show similar block affinities and kinetics. Tests of 20-mer L-and D-Shaker peptides on Shaker(D2-46) channels confirmed this expectation with little difference in blocking affinity ( Fig. 3a-d and Supplementary Fig. 7 ). Unblock from either peptide occurred in a fashion consistent with a single-step occlusion mechanism not dependent on stereochemistry Fig. 3e, f) . Thus, the key determinants that define block behaviour of the Shaker ball peptide within the Shaker inner pore do not include a steric interaction. However, this does not exclude that a Shaker peptide might electrostatically interact with positions that may influence block affinity 13, 25 or that a form of two-step inactivation also proposed in Kv channels 8, 25 may occur (see Supplementary Text) .
Our results do not identify the location of the b3a L-peptide binding site. For Shaker K 1 channels, the ability of TEA to slow inactivation onset argues that TEA and the Shaker N terminus compete for a common position within the inner pore 26 . For BK inactivation, the inability of pore blockers to interfere with inactivation onset is a natural consequence of the two-step inactivation mechanism 20 . If a fast blocker binds with similar affinity to both O and O* states and the rate-limiting inactivation step is the transition from O to O*, even if a blocker competitively inhibits movement of an inactivation domain into a position of inactivation, it will not slow the onset of inactivation ( Supplementary Fig. 8 ). However, the effects of blockers on slow tail current allow mechanistically informative tests of the interactions of pore blockers and the inactivation domain ( Supplementary Fig. 8 ). We considered three cases: one in which blocker competitively impedes formation of O* and subsequently I* ( Supplementary Fig. 8a, model  1) , one in which blocker does not impede any aspect of the inactivation process ( Supplementary Fig. 8a, model 2) and two variants of a model ( Supplementary Fig. 8a , models 3 and 39) in which block competitively inhibits inactivation. Each scheme results in distinct predictions about blocker effects on the time course of b3a-mediated currents, both for onset of inactivation ( Supplementary Fig. 8b, d ) and for tail currents ( Supplementary Fig. 8c, d ). Only the model (model 3) in which a pore blocker competitively prevents the O*RI* transition predicts that blocker will reduce both tail current amplitude and duration (Fig. 4a, b) .
We therefore tested the effects of the pore blocker, TBA 27 , on b3amediated tail currents; both peak tail current and tail current time constant were reduced ( Fig. 4c, d) . These effects occur at concentrations in excess of the TBA blocking affinity for open BK channels (approximately 0.9 mM (ref. 27)), but consistent with the competitive model (Fig. 4b) . Similar results were obtained with the bulky blocker, bbTBA 28 (Fig. 4e, f) . We conclude that b3a-mediated inactivation involves movement of part of the b3a N terminus into a position that can also be occupied by BK pore blockers. Although it has been assumed that BK b-subunit N termini produce inactivation by occupying a site within the BK channel central cavity, this provides the first direct evidence of this assumption. Our results do not establish the position of the stereospecific interaction between b3a peptide and the a-subunit, but we suggest that the binding-site determinants are on the walls of the cavernous BK inner pore 29, 30 .
These results demonstrate at the single molecule level that an intrinsically disordered peptide domain can bind in a stereospecific Supplementary Fig. 8a , model 3) as blocker concentration increases. b, Model predictions for normalized tail current amplitude (I Blocker /I Ctrl ) and tail current decay (t Blocker / t Ctrl ) as a function of blocker concentration/K d (0) (binding constant at 0 mV). c, BK a-subunits coexpressed with construct D20A (b3a N terminus appended to b2 subunit, see Methods). Currents were activated with 10 mM Ca 21 , with the indicated voltage steps, and 2 (red) or 10 (blue) mM TBA. d, Effect of TBA concentration on tail current amplitude and time constant plotted assuming K d (0) for TBA is 0.9 mM. e, BK a 1 D20A traces for control solution and with 200 and 400 mM bbTBA. f, Effect of bbTBA on tail current amplitude and time constant with a K d (0) for bbTBA block of 6 mM. Error bars, means 6 s.e.m. of 3-5 measurements.
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fashion to a target protein, thereby mediating physiological effects. An important implication of the mechanism by which the b3a N terminus prolongs tail current is that the O* state-although an open, ionconducting conformation-is unable to close until the b3a peptide dissociates from the channel. We propose that not only does this intrinsically disordered peptide bind to a stereospecific site on or near the BK channel inner pore, but that this binding allosterically stabilizes the BK channel in an open conformation. The requirement for stereospecific binding in BK inactivation contrasts with Shaker inactivation, which is mediated largely by hydrophobic interactions of its inactivation domain with the Shaker pore. In each case, inactivation domain disorder may be required to facilitate movement of the N-terminal inactivation segment through narrow pathways to reach blocking positions. The differences in stereochemical requirements may be required by structural differences in the ion channel pores: the Shaker domain may fit more snugly in the narrower open Kv channel 8 , whereas in the larger BK channel inner pore 30 stereospecific binding may be required to achieve the affinity necessary for inhibition or to modulate channel gating.
METHODS SUMMARY
Recordings of channel activity used inside-out patches from Xenopus oocytes expressing either wild-type BK channels along with wild-type or mutant b3a subunits or Shaker-IR channels. All recordings were with symmetrical K 1 solutions, with solutions of calibrated Ca 21 applied to the cytosolic face of BK channels. Solution control and exchange at the cytosolic face of a patch were done with a multi-barrel pipette. Currents were typically acquired at 100 kHz sampling, with filtering at 10 kHz. Single-channel records used off-line subtraction based on nullsweeps. D-and L-peptides for b3a N termini (MQPFSIPVQITLQGSRRRQGR-NH2) or Shaker N termini MAAVAGLYGLGEDRQHRKKQ-NH2) were obtained commercially. Simulations of different models of inactivation used the IChSim program. 21-mer D-and L-b3a peptides were dissolved at a final peptide concentration of 2 mM for acquisition of one-dimensional proton spectra and twodimensional homonuclear phase-sensitive total correlation spectroscopy (TOCSY), NOESY and rotating-frame NOE spectroscopy (ROESY) spectra. Circular dichroism spectra were generated with a Jasco J715 after dilution of the NRM samples in water.
METHODS
Constructs. The mSlo1 construct (GenBank accession number NP_034740) was placed in the pXMX expression construct 31 . The mouse b3a construct (GenBank accession number NP_001182003.1) was described in previous work 32 . In some experiments, construct D20A, in which the human b3a N terminus was attached to a human b2 construct (N-terminal removed), was used 21 . This construct avoids the outward rectification that arises from the extracellular loop of the b3 subunit 33 . The D20A N terminus begins with 55 residues from human b3a that are then appended to human b2 beginning at the b2 first transmembrane segment (hb3a:1-55);(hb2:47-235). A Shaker-B construct was provided by L. Jan 34 and residues 2-46 of the N terminus were deleted by X.-M. Xia to generate the noninactivating ShakerB(D2-46). Heterologous expression in oocytes. Stage IV Xenopus laevis oocytes were used for expression of Slo1 and b3a constructs. Slo1 a and b3 antisense RNA (cRNA), prepared at approximately 1 mg ml 21 , were first diluted to 1:20 and 1:10, respectively, and the diluted solutions mixed in equal amounts. Assuming that the initial b-subunit RNA stock is approximately three-to fourfold higher in molar amount than the Slo1 RNA stock, the final b3a:a molar injection ratio is approximately 6-8:1. For singlechannel patches, the amount of injected RNA was reduced about 10-to 100-fold. Electrophysiology. Borosilicate capillary tubes (Drummond Microcaps, 100 ml) were pulled to diameters resulting in access resistance of 1-2 MV, coated with Sylgard (Sylgard 184, Dow Chemical Corp.) and fire-polished. Currents were recorded in the inside-out configuration 35 using an Axopatch 200 amplifier (Molecular Devices) and the Clampex program from the pClamp software package (Molecular Devices).
Patches with gigaohm seals were formed in normal frog Ringer (in mM: 115 NaCl, 2.5 KCl, 1.8 CaCl 2 , 10 HEPES, pH 7.4) and then, after excision, moved into flowing test solutions to control the solution bathing the membrane face. The pipette/extracellular solution was (in mM): 140 K-methanesulphonate, 20 KOH, 10 HEPES, 2 MgCl 2 , pH 7.0. Test solutions bathing the cytoplasmic face of the patch membrane contained (in mM) 140 K-methanesulphonate, 20 KOH, 10 HEPES, with pH adjusted to 7.0 KOH. HEDTA (5 mM) was used for 10 mM Ca 21 solutions and 5 mM EGTA for 0 mM Ca 21 . The 10 mM Ca 21 solution was titrated to appropriate pCa with Ca-MES and calibrated against solutions of defined Ca 21 concentrations (World Precision Instruments) using a Ca 21 -sensitive electrode. Solutions bathing the cytosolic face of the membrane were controlled by a local application system containing up to six independent lines. Experiments were at room temperature (22-24 uC) and chemicals for solution preparation were from Sigma. Data analysis. Analysis of current recordings and simulated currents was accomplished either with Clampfit (Molecular Devices) or with programs written in this laboratory. Single-channel traces were first processed using digital subtraction of leak and capacity currents defined from traces lacking any channel openings. For ensemble averaging of Shaker single-channel openings, each sweep was first filtered at 1 kHz (acquisition at 50 kHz with filtering at 5 kHz). Simulation of currents. Current simulations were accomplished with the IChSim program (http://www.ifisica.uaslp.mx/,jadsc/ichsim.htm) developed at the Physics Institute of the University of San Luis Potosi, Mexico, by J. A. De Santiago Castillo. Solution NMR. Peptides (21-mer D-and L-b3a) were dissolved in 20 mM potassium phosphate, 20 mM sodium chloride, pH 7.0, 10% D 2 O with a final peptide concentration of 2 mM. One-dimensional proton spectra and two-dimensional homonuclear phase-sensitive TOCSY, NOESY and ROESY spectra were recorded on a 600 MHz Bruker Avance III spectrometer equipped with QCI cryoprobe. NOESY and ROESY spectra were acquired with a mixing time of 300 ms, TOCSY with an 80 ms mixing time. All two-dimensional homonuclear experiments were acquired with 512 points in the indirect dimension, and 16 scans per increment. Spectra were processed with NMRpipe and displayed using NMRViewJ (two-dimensional spectra) or IgorPro (one-dimensional spectra). Circular dichroism spectra. The NMR samples were diluted 40-fold in water for measurement of circular dichroism spectra using a Jasco J715. Peptides. L-and D-amino-acid b3a peptides and L-and D-20-mer ShakerB ball peptides were custom synthesized by Biomolecules Midwest with an amidated carboxy (C) terminus and NH 2 -N terminus, and purified by high-performance liquid chromatography to over 95% purity. Both 20 and 21 L-amino-acid versions of the b3a peptides were used in separate experiments. The 21-mer b3a peptide contains an additional R in position 21 and shows a faster forward rate of block than the 20-mer. The sequence of the 20-mer ShakerB ball peptides was MAAVAGLYGLGEDRQHRKKQ-NH2, identical to 12 ShakerB peptides used in previous work 6, 13 .
